摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

高圣草酚 | 446-71-9

中文名称
高圣草酚
中文别名
高胜草酚
英文名称
homoeriodictyol
英文别名
(2S)-homoeriodictyol;hesperetin;(2S)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydrochromen-4-one
高圣草酚化学式
CAS
446-71-9
化学式
C16H14O6
mdl
——
分子量
302.284
InChiKey
FTODBIPDTXRIGS-ZDUSSCGKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    225-227°C (dec.)
  • 比旋光度:
    D20 -28° (alc)
  • 沸点:
    583.8±50.0 °C(Predicted)
  • 密度:
    1.458±0.06 g/cm3(Predicted)
  • LogP:
    2.720 (est)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    22
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    96.2
  • 氢给体数:
    3
  • 氢受体数:
    6

安全信息

  • 储存条件:
    室温

SDS

SDS:6c4cc4f69a74cd08d006994e38e89f6d
查看

制备方法与用途

高绒霉素是绒霉素在血浆和尿液中的一种类黄酮代谢产物,而枇杷苷则是一种强大的抗氧化剂。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    高圣草酚 在 C9H8IO4Pol 作用下, 以 二甲基亚砜 为溶剂, 反应 2.0h, 以98%的产率得到圣草酚
    参考文献:
    名称:
    Selective and efficient oxidative modifications of flavonoids with 2-iodoxybenzoic acid (IBX)
    摘要:
    2-Iodoxybenzoic acid (IBX), a mild and efficient hypervalent iodine oxidant, has been utilised in different reaction conditions to perform several efficient oxidative modifications of flavonoids. Fine-tuning of the reaction conditions allowed remarkably selective modifications of these compounds. At room temperature, IBX proved to be an excellent reagent for a highly regioselective aromatic hydroxylation of monohydroxylated flavanones and flavones, generating the corresponding catecholic derivatives showing high antioxidant activity. At 90 degrees C, IBX efficiently dehydrogenated a large panel of methoxylated flavanones to their corresponding flavones exhibiting anticancer activity. IBX polystyrene has also been utilised to increase the recovery of highly polar compounds. Following the first oxidation, the reagent was recovered and reused in several runs without loss of efficiency and selectivity. The first example of an application of IBX polystyrene in a dehydrogenation reaction has been described. (c) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2010.06.014
  • 作为产物:
    描述:
    4,2',4',6'-tetraacetoxy-3-methoxy-chalcone 在 乙醇 、 camphor-10-sulfonic acid 作用下, 生成 高圣草酚
    参考文献:
    名称:
    Tatsuta, Nippon Kagaku Kaishi/Journal of the Chemical Society of Japan, 1940, vol. 61, p. 1048
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER
    申请人:TACHDJIAN Catherine
    公开号:US20120041078A1
    公开(公告)日:2012-02-16
    The present invention includes methods of stabilizing one or more sweet enhancers when they are exposed to a light source as well as liquid compositions containing one or more sweet enhancers and one or more photostabilizers.
    本发明包括在甜味增强剂暴露于光源时稳定一个或多个甜味增强剂的方法,以及包含一个或多个甜味增强剂和一个或多个光稳定剂的液体组合物。
  • [EN] AMINO ACID DERIVATIVES AND THEIR USE AS FLAVOR MODIFIERS<br/>[FR] DÉRIVÉS D'ACIDES AMINÉS ET LEUR UTILISATION EN TANT QUE MODIFICATEURS DE GOÛT
    申请人:FIRMENICH & CIE
    公开号:WO2021209345A1
    公开(公告)日:2021-10-21
    The present invention provides derivatives of glutamine of formula (I) and derivatives of arginine of formula (II), and the use of such compounds as flavor modifiers. The invention further provides the use of such derivatives of glutamine and arginine to enhance the salty and umami taste of ingestible compositions as ingestible compositions that include such derivatives of glutamine and arginine and bulking agents.
    本发明提供了公式(I)的谷氨酰衍生物和公式(II)的精氮酸衍生物,以及将这些化合物用作风味调节剂的用途。该发明进一步提供了利用这些谷氨酰和精氮酸衍生物增强可摄入组合物的咸味和鲜味的用途,作为包含这些谷氨酰和精氮酸衍生物以及增稠剂的可摄入组合物。
  • Controlled Release of Nitric Oxide And Drugs From Functionalized Macromers And Oligomers
    申请人:Bezwada Rao S.
    公开号:US20120035259A1
    公开(公告)日:2012-02-09
    The present invention provides NO and, optionally, drug releasing macromers and oligomers wherein the drug molecule and NO releasing moiety are linked an absorbable macromer or oligomeric chain susceptible to hydrolytic degradation and wherein the macromer or oligomer comprises of repeat units derived from safe and biocompatible molecules such as glycolic acid, lactic acid, caprolactone and p-dioxanone. Furthermore, the present invention relates to controlled release of nitric oxide (NO) and/or drug molecule from a NO and drug releasing macromer or oligomer. Moreover, the present invention also relates to medical devices, medical device coatings and therapeutic formulations comprising of nitric oxide and drug releasing macromers and oligomers of the present invention.
    本发明提供了一氧化氮(NO)和可选的药物释放的大分子和寡聚物,其中药物分子和一氧化氮释放部分通过可吸收的大分子或可水解降解的寡聚物链连接,并且大分子或寡聚物由来自诸如乙醇酸、乳酸、己内酰胺和对二恶烷等安全且生物相容的分子的重复单元组成。此外,本发明还涉及从一氧化氮和/或药物分子释放的大分子或寡聚物控制释放一氧化氮(NO)。此外,本发明还涉及包含本发明的一氧化氮和药物释放大分子和寡聚物的医疗器械、医疗器械涂层和治疗方法。
  • ABSORBABLE BRANCHED POLYESTERS AND POLYURETHANES
    申请人:Bezwada Biomedical, LLC
    公开号:US20140142199A1
    公开(公告)日:2014-05-22
    The present invention relates to the discovery of a new class of hydrolysable isocyanates, hydrolysable branched polyols and branched absorbable polyesters and polyurethanes prepared therefrom. The resultant absorbable polymers are useful for drug delivery, stents, highly porous foam, reticulated foam, tissue engineering, tissue adhesives, adhesion prevention, bone wax formulations, medical device coatings, surface modifying agents and other implantable medical devices. In addition, these absorbable polymers can have a controlled hydrolytic degradation profile.
    本发明涉及一种新型可水解异氰酸酯、可水解支链多元醇及其制备的支链可吸收聚酯和聚氨酯的发现。由此得到的可吸收聚合物可用于药物输送、支架、高孔隙率泡沫、网状泡沫、组织工程、组织粘合剂、防止粘连、骨蜡制剂、医疗设备涂层、表面改性剂以及其他可植入医疗设备。此外,这些可吸收聚合物可以具有受控的水解降解特性。
  • [EN] SMALL MOLECULE COMPOUNDS TO SUPPORT HEALTHY HUMAN AGING<br/>[FR] COMPOSÉS À PETITES MOLÉCULES POUR FAVORISER UN VIEILLISSEMENT HUMAIN SAIN
    申请人:CARDAX PHARMA INC
    公开号:WO2018183353A1
    公开(公告)日:2018-10-04
    Disclosed herein are methods of activating expression of the FOXO3 gene in a subject comprising administering to a subject small molecule compound (such as astaxanthin and/or one or more astaxanthin derivatives), or pharmaceutically acceptable salts thereof, in an amount sufficient to at least partially increase the amount of FoxO3 expressed in the subject.
    本文揭示了一种激活主体中FOXO3基因表达的方法,包括向主体施用小分子化合物(如虾青素和/或一个或多个虾青素衍生物)或其药用可接受盐,以足够数量至少部分增加主体中表达的FoxO3的方法。
查看更多